Selank
Approved (Russia/Ukraine)Selank (TP-7)
- Category
- Cognitive & Neuroprotection
- Aliases
- TP-7, Selanc
- Administration
- Intranasal spray, Subcutaneous injection
Documented benefits
Tier 1 · Peer-reviewed / regulatoryBenefit categories
Cognitive & Neuroprotection
Selank's defining research application — an anxiolytic peptide studied for calming effects without sedation.
Anxiety reduction
Modulates GABA-A receptor activity to reduce anxiety, similar in target to benzodiazepines but without the sedating effect.
BDNF elevation
Raises levels of a protein essential for the growth and maintenance of neural connections.
Cognitive enhancement
Supports mental clarity as a downstream effect of its calming, non-sedating action on brain chemistry.
Improved focus
Many users report steadier concentration, consistent with its regulation of serotonin and dopamine systems.
Mood stabilization
Regulates serotonin, dopamine, and noradrenaline systems together, rather than targeting a single neurotransmitter.
Neuroprotection
Its cytokine-modulating activity is studied for protecting neurons from stress-related inflammatory damage.
Stress resilience
Inhibits the breakdown of the body's natural enkephalin stress-response compounds, extending their calming effect.